Resverlogix Corp. (RVXCF)

[growacet]

I think publicity is overstating things.......

If Don was on BNN talking up Apabetalone's Alzheimer's potential, along with media publications, investor videos and lots of buzz in stock based social media....if all that was happening I'd think there was a PR publicity campaign going on.

From what I've seen....and please correct me if I'm missing something...from what I have seen:

-Dr. Cummings of the Cleveland Clinic gave a presentation to a scientific conference in China about Apabetalone's potential to treat Alzheimer's.

https://www.ctad-asia.com/sites/default/files/inline-files/ASIA%20CTAD%2B%20page%20de%20couv4_0.pdf

Nothing in there about Resverlogix being a publicly traded company, the name only comes up 4 times in identifying the company as being associated with certain individuals.

-Then today we get a PR about the presentation having taken place:

https://ca.finance.yahoo.com/news/resverlogix-presents-clinical-trials-alzheimer-120000667.html

Nothing came out prior announcing the company would be attending...but thanks to Bear over on Agora investors who keep an eye on that forum already knew it was coming.

-The only thing that has a hint of publicity to it is the report put out by Zacks:

http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2018/RVX-Apabetalone-A-Potential-Alzheimers-Play/default.aspx

Resverlogix has been paying this guy for years to cover the company, 30K a year. And quite frankly I'm convinced that the only people reading his reports are those who've already invested in RVX/RVXCF anyway. Why do they pay him $30K per yr as per the disclosure? IMO its so they can tell whiny shareholders: "look, we're trying to build shareholder value here, we're paying this guy for coverage".

And frankly I think his $5 PT is a joke....but I expect that, if things play out the way I think they will, I expect that some will hand their shares over to others in and around that price on the basis of that target being reached.

If I'm right those buying won't be basing their purchasing on some report put out by Zacks.